These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30521080)

  • 1. Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care.
    Koelmeyer LA; Borotkanics RJ; Alcorso J; Prah P; Winch CJ; Nakhel K; Dean CM; Boyages J
    Cancer; 2019 Mar; 125(6):854-862. PubMed ID: 30521080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
    Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
    Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
    Shah C; Zambelli-Weiner A; Delgado N; Sier A; Bauserman R; Nelms J
    Breast Cancer Res Treat; 2021 Feb; 185(3):709-740. PubMed ID: 33245458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis.
    Ridner SH; Dietrich MS; Cowher MS; Taback B; McLaughlin S; Ajkay N; Boyages J; Koelmeyer L; DeSnyder SM; Wagner J; Abramson V; Moore A; Shah C
    Ann Surg Oncol; 2019 Oct; 26(10):3250-3259. PubMed ID: 31054038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioimpedance Spectroscopy for Breast Cancer Related Lymphedema Assessment: Clinical Practice Guidelines.
    Shah C; Vicini FA; Arthur D
    Breast J; 2016 Nov; 22(6):645-650. PubMed ID: 27487985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy.
    Whitworth PW; Cooper A
    Breast J; 2018 Jan; 24(1):62-65. PubMed ID: 29063664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
    Shah C; Whitworth P; Valente S; Schwarz GS; Kruse M; Kohli M; Brownson K; Lawson L; Dupree B; Vicini FA
    Breast Cancer Res Treat; 2023 Feb; 198(1):1-9. PubMed ID: 36566297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of bioimpedance spectroscopy for prospective surveillance and early diagnosis of breast cancer-related lymphedema.
    Forte AJ; Huayllani MT; Boczar D; Avila FR; Kassis S; Ciudad P; Lu X; Moore PA; McLaughlin SA
    Breast Dis; 2021; 40(2):85-93. PubMed ID: 33646139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care.
    Stout NL; Pfalzer LA; Springer B; Levy E; McGarvey CL; Danoff JV; Gerber LH; Soballe PW
    Phys Ther; 2012 Jan; 92(1):152-63. PubMed ID: 21921254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing a prospective surveillance and early intervention model of care for breast cancer-related lymphedema into clinical practice: application of the RE-AIM framework.
    Koelmeyer L; Gaitatzis K; Ridner SH; Boyages J; Nelms J; Hughes TM; Elder E; French J; Ngui N; Hsu J; Stolldorf D
    Support Care Cancer; 2021 Feb; 29(2):1081-1089. PubMed ID: 32613370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioimpedance spectroscopy is not associated with a clinical diagnosis of breast cancer-related lymphedema.
    Spitz JA; Chao AH; Peterson DM; Subramaniam V; Prakash S; Skoracki RJ
    Lymphology; 2019; 52(3):134-142. PubMed ID: 31874125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer-Related Lymphedema (BCRL) and Bioimpedance Spectroscopy: Long-Term Follow-Up, Surveillance Recommendations, and Multidisciplinary Risk Factors.
    Jeffers EJ; Wagner JL; Korentager SS; Larson KE; Balanoff CR; Baker J; Chollet-Hinton L; Kilgore LJ
    Ann Surg Oncol; 2023 Oct; 30(10):6258-6265. PubMed ID: 37535267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous bypass surgical outcomes in breast cancer-related lymphedema?
    Sutherland A; Wagner JL; Korentager S; Butterworth J; Amin AL; Balanoff CR; Hangge A; Larson KE
    Breast Cancer Res Treat; 2021 Feb; 186(1):1-6. PubMed ID: 33392840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
    Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing rates of chronic breast cancer-related lymphedema with screening and early intervention: an update of recent data.
    Whitworth P; Vicini F; Valente SA; Brownson K; DuPree B; Kohli M; Lawson L; Shah C
    J Cancer Surviv; 2024 Apr; 18(2):344-351. PubMed ID: 35947288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
    Kaufman DI; Shah C; Vicini FA; Rizzi M
    Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive review of bioimpedance spectroscopy as a diagnostic tool for the detection and measurement of breast cancer-related lymphedema.
    Seward C; Skolny M; Brunelle C; Asdourian M; Salama L; Taghian AG
    J Surg Oncol; 2016 Oct; 114(5):537-542. PubMed ID: 27393376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental and Analytical Comparisons of Tissue Dielectric Constant (TDC) and Bioimpedance Spectroscopy (BIS) in Assessment of Early Arm Lymphedema in Breast Cancer Patients after Axillary Surgery and Radiotherapy.
    Lahtinen T; Seppälä J; Viren T; Johansson K
    Lymphat Res Biol; 2015 Sep; 13(3):176-85. PubMed ID: 26305554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective Study of L-Dex Values in Breast Cancer Patients Pretreatment and Through 12 Months Postoperatively.
    Ridner SH; Dietrich MS; Spotanski K; Doersam JK; Cowher MS; Taback B; McLaughlin S; Ajkay N; Boyages J; Koelmeyer L; DeSnyder S; Shah C; Vicini F
    Lymphat Res Biol; 2018 Oct; 16(5):435-441. PubMed ID: 30130147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review.
    Shah C; Arthur DW; Wazer D; Khan A; Ridner S; Vicini F
    Cancer Med; 2016 Jun; 5(6):1154-62. PubMed ID: 26993371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.